Pfenex Inc. | |
Stock Exchange | NYSE |
EPS |
$1.09 |
Market Cap |
$230.91 M |
Shares Outstanding |
31.5 M |
Public Float |
30.77 M |
Address |
10790 Roselle Street San Diego California 92121 United States |
Employees | - |
Website | http://www.pfenex.com |
Updated | 07/08/2019 |
Pfênex, Inc. is a clinical-stage biotechnology company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes biosimilars and vaccines. The company was founded on November 19, 2009 and is headquartered in San Diego, CA. |